A tumor, looking like a colored blob, in the cellview environment which divides it up into hundreds of tiny rectangles
A screencapture of a tumor microenvironment in cellview. A magnified cell has florescent pink and green superimpositions and is sectioned with a cyan grid

Researchers at the Mark Foundation Center for Advanced Genomics and Imaging from the Institute for Data-Intensive Engineering and Science (IDIES) at Johns Hopkins University, and the Bloomberg-Kimmel Institute for Cancer Immunotherapy have developed a robust platform to guide specific immunotherapeutic regimens by predicting which cancers are most likely respond to treatment.

Revolutionary and interdisciplinary, the CellView platform at the core of the AstroPath project makes use of sky-mapping algorithms originally developed for astronomy.

Advanced immunofluorescence imaging of cancer biopsies, combined with the strategy developed by AstroPath allows researchers to navigate the tumor landscape and develop smarter, more personalized treatment.